News: PerkinElmer Inc (PKI.N)
PKI.N on New York Stock Exchange
35.07USD
1 Aug 2013
35.07USD
1 Aug 2013
Price Change (% chg)
$0.98 (+2.87%)
$0.98 (+2.87%)
Prev Close
$34.09
$34.09
Open
$34.32
$34.32
Day's High
$35.09
$35.09
Day's Low
$34.07
$34.07
Volume
321,285
321,285
Avg. Vol
271,282
271,282
52-wk High
$35.86
$35.86
52-wk Low
$24.71
$24.71
Select another date:
Thu, Aug 1 2013
PerkinElmer lower profit exceeds Street expectations
- PerkinElmer Inc on Thursday reported lower second-quarter earnings that exceeded tempered expectations after Wall Street had been caught off guard by a disappointing first quarter.
PerkinElmer lower second quarter profit exceeds Street expectations
- PerkinElmer Inc on Thursday reported lower second-quarter profit that exceeded tempered expectations after Wall Street had been caught off guard by a disappointing first quarter.
PerkinElmer profit misses expectations, lowers forecast
- PerkinElmer Inc on Thursday reported lower-than-expected first-quarter profit and decreased its full-year forecast as difficult economic conditions and a stronger dollar hurt sales in Europe and Japan.
Select another date:
- PerkinElmer Management Discusses Q2 2013 Results - Earnings Call Transcript
- 1 Reason PerkinElmer May Be Headed for a Slowdown
- Detecting Investment Potential In Medical Diagnostics Companies
- Why Royalty And Milestone Partnership Dynamics Imply Trovagene Could Triple
- Mad Money Uncovered: Perkin Elmer
- Cramer's Top Stock Picks: AAPL BBY NFLX BRK.B DPZ PKI
Press Releases
- PerkinElmer Announces Financial Results for the Second Quarter of 2013
- Technical Scrutiny: Thermo Fisher, Agilent Technologies, Laboratory Corp. of America, and PerkinElmer
- Financial Results, Earnings Schedules, Quarterly Dividends, and Top Rankings - Research Report on Quest Diagnostics, PerkinElmer, PAREXEL, Covance, and ICON
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer Launches New Live Cell Capabilities for Operetta® High Content Imaging System
- Improving Clinical Outcomes, Expanded Services, Earnings Schedule and Guidance - Research Report on Abbott, Baxter, PerkinElmer, Allscripts and Parexel
- PerkinElmer to Hold Earnings Call on Thursday, August 1, 2013
- Outlook Remains Positive with New Licensing Agreements and Successful Product Launches - Research Report on Restoration Life Technologies, Thermo Fisher, Agilent, Quest and PerkinElmer
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer Introduces New Generation of Tandem Mass Spectrometer

